Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia
NCT06264414 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 262
Last updated 2024-02-20
Summary
The purpose of this study is to assess the safety and efficacy of the DTT106 in the treatment of erectile dysfunction associated with benign prostatic hyperplasia
Conditions
- Prostatic Hyperplasia, Benign
- Erectile Dysfunction
Interventions
- DRUG
-
DTT106
oral route
- DRUG
-
Dutasteride-Tamsulosin
oral route
Sponsors & Collaborators
-
EMS
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-02-28
- Primary Completion
- 2026-06-30
- Completion
- 2027-07-31
Countries
- Brazil
Study Locations
More Related Trials
-
Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer
NCT00244309 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Sexual Function Study for BPH Subjects
NCT01777269 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Tadalafil in Men With Benign Prostatic Hyperplasia
NCT00970632 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Tadalafil, Tamsulosin, and Their Combinations in Treating Lower Urinary Tract Symptoms in BPH Patients with Prostate Volumes ≤ 40 Ml: a Prospective Comparative Study
NCT06809205 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms
NCT02252367 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia
NCT02245529 ·Status: COMPLETED
-
Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients
NCT05558007 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH
NCT02390882 ·Status: COMPLETED ·Phase: PHASE3
-
Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia Under Fixed Dose combΙnaTion Treatment With Dutasteride and Tamsulosin . PROSPERITY Group of Studies (I&II)
NCT04831476 ·Status: COMPLETED
-
This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples
NCT01957189 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia
NCT01673490 ·Status: TERMINATED ·Phase: PHASE4
-
A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.
NCT00609596 ·Status: COMPLETED ·Phase: PHASE1
-
Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia
NCT00701779 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients
NCT03246880 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers.
NCT04485585 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Benign Prostatic Hyperplasia
NCT01152190 ·Status: COMPLETED ·Phase: PHASE3
-
FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia
NCT02244255 ·Status: COMPLETED ·Phase: PHASE4
-
Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)
NCT00527605 ·Status: COMPLETED ·Phase: PHASE3
-
Administration of Tadalafil in Patients With Benign Prostatic Hyperplasia
NCT06466369 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia
NCT02058368 ·Status: COMPLETED ·Phase: PHASE3
-
Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects
NCT00368979 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia
NCT02827578 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
NCT01139762 ·Status: COMPLETED ·Phase: PHASE3
-
Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State
NCT02058576 ·Status: COMPLETED ·Phase: PHASE1
-
Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)
NCT00939120 ·Status: COMPLETED ·Phase: PHASE4